Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
Iirc the Chinese authorities have just approved the use of RATs for mass testing so we may see availability issues in the west if they start witholding them for domestic consumption.
@gizmo555, if you extrapolate Hong Kong death rate per million it would equate to around 2500 deaths per day in the UK, more than twice our alpha peak. Worrying considering Hong Kong have a vaccination rate of around 80% (although significantly lower in the 80+ demographic). No wonder China is worried as it could result in 30k per day if they lose control, I don't think they can control ba.2 unless they put in place the most draconian measures which wouldn't surprise me either.
The big concern is the massive amount of replication space the virus is getting and ba.2 is not less virulent than ba.1 so it isn't attenuating further.
I'd be more concerned about the ba.2 sub variant tearing through Hong Kong than deltacron. Deaths per million 3 times higher even than the US at their peak during the alpha wave. The vaccination profile for Hong Kong is similar to most Asian countries yet they are getting hammered.
It shouldn't be forgotten that they attempted to have a closed AGM in a deliberate attempt to avoid being held to account for last year's performance. A practice that's frowned upon in these days of computers and electronic communication. They only relented because shareholders kicked off and even then cherry picked soft ball questions.
Hong Kong is likely a combination of a naive population and a unique dominant mutation of ba.2. Good job we're scrupulously surveiling our border entry points, oh yeah we're not doing it at all
https://t.co/zVARZ4pqd8
It had better be RNSd, they announced it's October (lol) launch by RNS, it's only 5 months late without any explanation. This is the only product launch from it/is since their acquisition 18 months ago, about time they justified the purchase price.
The RNS was of no consequence, it's issued on the first trading day of every month.
Quite some achievement for a debt free company to be trading below cash + the acquisition cost of it/is. We are valued at less than pre pandemic. Stunning achievement by the uninvested CEO.
I bet we see a flurry of LFT accreditations now. The actions of UKHSA were nothing more than to provide cover for the government splurging vast sums on Chinese tests.
Over Xmas I did a few tests when coming into contact with elderly relatives who have a raft of underlying conditions, both the missus and I had some symptoms that would be consistent with omicron. Negative every time but at least some precautions were taken as they'd thus far avoided getting covid.
People entering some care settings may not get the choice, I know a manager of one provider who is making it a condition of visiting, having lost both service users and staff over the last 2 including to 'mild' omicron.
Give it a month and Johnson will be doing another u turn when cases start surging again. Ba.2 will become dominant in the UK this week - 1 month to go from <2% to >50% of sequences , we're probably very close to the bottom of the decline of cases in this wave.
As for biosynex, 4% gets them nowhere they will have to increase regardless of their intents. Takeover would be good but I'm struggling to see how it gets financed, a distribution deal would give us an easier 'in' to European territories where we've struggled badly imo.
@kaeran they'll be back peddling by April. There'll be a panic distribution of 4th doses for all adults for which I agree there'll be a poor take up. How many times have we been on an irreversible course according to the PM?
It's not likely to be vanilla ba.2 that gets a grip here ultimately, more likely one of the sub variants of it which are already outcompeting ba2 (which had already displaced ba1) in places such as Denmark.